400 related articles for article (PubMed ID: 7686798)
1. Basophil releasability in patients with hymenoptera venom allergy.
Radermecker MF; Leclercq MD; Mariz SD; Louis RE
Int Arch Allergy Immunol; 1993; 101(3):283-7. PubMed ID: 7686798
[TBL] [Abstract][Full Text] [Related]
2. Cytokine modulation of basophil histamine release in wasp-venom allergy.
Radermecker M; Louis R; Leclercq M; Weber T; Corhay JL; Bury T
Allergy; 1994 Sep; 49(8):641-4. PubMed ID: 7544549
[TBL] [Abstract][Full Text] [Related]
3. [The basophilic histamine liberation test as a diagnostic method in Hymenoptera venom allergy].
Przybilla B; Ring J; Wielgosch J
Hautarzt; 1988 Oct; 39(10):662-70. PubMed ID: 2466814
[TBL] [Abstract][Full Text] [Related]
4. Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy.
Korošec P; Šilar M; Kopač P; Eržen R; Zidarn M; Košnik M
Int Arch Allergy Immunol; 2016; 171(2):89-101. PubMed ID: 27907922
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release.
Sainte-Laudy J; Sabbah A; Drouet M; Lauret MG; Loiry M
Clin Exp Allergy; 2000 Aug; 30(8):1166-71. PubMed ID: 10931125
[TBL] [Abstract][Full Text] [Related]
6. Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy.
Eberlein-König B; Rakoski J; Behrendt H; Ring J
J Investig Allergol Clin Immunol; 2004; 14(1):10-6. PubMed ID: 15160437
[TBL] [Abstract][Full Text] [Related]
7. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.
Platz IJ; Binder M; Marxer A; Lischka G; Valent P; Bühring HJ
Int Arch Allergy Immunol; 2001 Dec; 126(4):335-42. PubMed ID: 11815741
[TBL] [Abstract][Full Text] [Related]
8. Human basophil releasability. I. Age-related changes in basophil releasability.
Marone G; Poto S; di Martino L; Condorelli M
J Allergy Clin Immunol; 1986 Feb; 77(2):377-83. PubMed ID: 2418093
[TBL] [Abstract][Full Text] [Related]
9. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study.
Sturm GJ; Böhm E; Trummer M; Weiglhofer I; Heinemann A; Aberer W
Allergy; 2004 Oct; 59(10):1110-7. PubMed ID: 15355471
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of diagnostic value of skin test, venom specific antibodies against EgE and basophil histamine release test in hymenoptera allergy].
Nittner-Marszalska M; Małolepszy J; Medrala W
Pneumonol Alergol Pol; 1993; 61(7-8):346-51. PubMed ID: 7691338
[TBL] [Abstract][Full Text] [Related]
11. Study of IgE-dependent basophil releasability in allergic patients.
Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry versus histamine release analysis of in vitro basophil degranulation in allergy to Hymenoptera venom.
Lambert C; Guilloux L; Dzviga C; Gourgaud-Massias C; Genin C
Cytometry B Clin Cytom; 2003 Mar; 52(1):13-9. PubMed ID: 12599177
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mechanisms of IL-3 induced histamine release and IL-3 priming effect on human basophils.
Okayama Y; Begishvili TB; Church MK
Clin Exp Allergy; 1993 Nov; 23(11):901-10. PubMed ID: 10779277
[TBL] [Abstract][Full Text] [Related]
14. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
[TBL] [Abstract][Full Text] [Related]
15. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
Gaddy JN; Busse WW
Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
[TBL] [Abstract][Full Text] [Related]
16. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.
Sabroe RA; Francis DM; Barr RM; Black AK; Greaves MW
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):651-8. PubMed ID: 9802375
[TBL] [Abstract][Full Text] [Related]
17. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of histamine release from human leucocytes by PAF.
Louis R; Bury T; Corhay JL; Radermecker MF
Agents Actions; 1994 Mar; 41(1-2):5-10. PubMed ID: 7521570
[TBL] [Abstract][Full Text] [Related]
19. Studies on human basophil releasability.
Marone G; Poto S; Giugliano R; Bonini S
Int Arch Allergy Appl Immunol; 1985; 77(1-2):103-6. PubMed ID: 2409008
[TBL] [Abstract][Full Text] [Related]
20. Human basophil chemotaxis and activation are regulated via the histamine H4 receptor.
Mommert S; Kleiner S; Gehring M; Eiz-Vesper B; Stark H; Gutzmer R; Werfel T; Raap U
Allergy; 2016 Sep; 71(9):1264-73. PubMed ID: 26948974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
